Bone Biologics (BBLG) EPS (Weighted Average and Diluted) (2016 - 2025)
Bone Biologics (BBLG) reported EPS (Weighted Average and Diluted) of -$0.14 for Q4 2025, down 207.69% year-over-year from $0.13 in Q4 2024, and up 62.16% quarter-over-quarter from -$0.37 in Q3 2025.
Bone Biologics (BBLG) EPS (Weighted Average and Diluted) (2016 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 7 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.14 in Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.14, down 207.69% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.16 (up 88.87% YoY), and the FY2025 annual result was -$2.65, up 90.85% from the prior year.
- EPS (Weighted Average and Diluted) advanced to -$0.14 in Q4 2025 per BBLG's latest filing, from -$0.37 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $3.39 in Q4 2023 and troughed at -$55.2 in Q1 2023.
- A 4-year average of -$7.51 and a median of -$1.36 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 113.97% in 2023 and fell as far as 283.09% in 2023.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$24.26 in 2022, then soared by 113.97% to $3.39 in 2023, then plunged by 96.17% to $0.13 in 2024, then sank by 207.69% to -$0.14 in 2025.
- Business Quant data shows BBLG's EPS (Weighted Average and Diluted) at -$0.14 in Q4 2025, -$0.37 in Q3 2025, and -$1.33 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.61 |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.14 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -1.33 |
| Mar 31, 2025 | -0.32 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | -14.21 |
| Jun 30, 2024 | -4.02 |
| Mar 31, 2024 | -1.31 |
| Dec 31, 2023 | 3.39 |
| Sep 30, 2023 | -4.90 |
| Jun 30, 2023 | -5.21 |
| Mar 31, 2023 | -55.20 |
| Dec 31, 2022 | -24.26 |
| Sep 30, 2022 | -3.53 |
| Jun 30, 2022 | -1.36 |
| Jun 30, 2018 | -0.29 |
| Jun 30, 2017 | 0.25 |
| Jun 30, 2016 | -0.13 |